The Biden administration has a 'timely plan for J&J booster shots,' too, surgeon general says
Federal health officials on Wednesday advised the more than 150 million Americans who've gotten two doses of the Pfizer-BioNTech and Moderna COVID-19 vaccines that they should get a third shot starting Sept. 20.
But what about the 14 million who opted for the one-and-done Johnson & Johnson vaccine? "We anticipate vaccine boosters will likely be needed" for them, too, Surgeon General Vivek Murthy said at a White House briefing. "We expect more data on J&J in the coming weeks. With those data in hand, we will keep the public informed of a timely plan for J&J booster shots."
The Biden administration is pushing a booster shot because the mRNA vaccines, Pfizer and Moderna, appear to be losing some efficacy against the much more transmissible Delta variant. There's less data for the Johnson & Johnson shot's longevity, though Johnson & Johnson told The New York Times it will "will share new data shortly regarding boosting with the Johnson & Johnson COVID-19 vaccine," probably "in the coming weeks."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"If you're doing data-driven decisions and you don't have the data, what can you do?" asked John Moore, a virologist at Weill Cornell Medicine. He told the Times he "would be very, very surprised" if the U.S. didn't approve a second J&J shot "in the reasonably near future," adding, "The federal government is well aware of the J.&J. situation. ... It's not being overlooked."
Dr. Dan Barouch, a virologist at Boston's Beth Israel Deaconess Medical Center, said new real-world data from health workers in South Africa has "very clear results showing that the single-shot J&J vaccine provided substantial protection against the Delta variant." Barouch and Moore said they expect that when the booster shot is approved, it will be for a second J&J dose, not Pfizer or Moderna.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Cicada-geddon: the fungus that controls insects like 'zombies'
Under The Radar Expert says bugs will develop 'hypersexualisation' despite their genitals falling off
By Chas Newkey-Burden, The Week UK Published
-
'Voters know Biden and Trump all too well'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
Is the Gaza war tearing US university campuses apart?
Today's Big Question Protests at Columbia University, other institutions, pit free speech against student safety
By Joel Mathis, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
Covid four years on: have we got over the pandemic?
Today's Big Question Brits suffering from both lockdown nostalgia and collective trauma that refuses to go away
By Chas Newkey-Burden, The Week UK Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
The hollow classroom
Opinion Remote school let kids down. It will take much more than extra tutoring for kids to recover.
By Mark Gimein Published
-
Excess screen time is making children only see what is in front of them
Under the radar The future is looking blurry. And very nearsighted.
By Devika Rao, The Week US Published
-
Covid-19: what to know about UK's new Juno and Pirola variants
in depth Rapidly spreading new JN.1 strain is 'yet another reminder that the pandemic is far from over'
By Arion McNicoll, The Week UK Published
-
Long-term respiratory illness is here to stay
The Explainer Covid is not the only disease with a long version
By Devika Rao, The Week US Published